Should we treat sepsis-induced DIC with anticoagulants?
Abstract Background Disseminated intravascular coagulation (DIC) is a common complication in sepsis because of crosstalk between the immune system and the coagulation system. Several anticoagulant agents have been tested in an attempt to improve the survival of patients with sepsis and sepsis-induce...
Main Author: | Yu Inata |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Journal of Intensive Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40560-020-0435-8 |
Similar Items
-
The application of anticoagulant therapy to sepsis
by: Jecko Thachil, et al.
Published: (2017-05-01) -
Review. Anticoagulant Therapy in Sepsis. The Importance of Timing
by: Scarlatescu Ecaterina, et al.
Published: (2017-04-01) -
Disseminated intravascular coagulation: A review of the topic
by: Alejandro Hernández-Martínez, et al.
Published: (2018-08-01) -
Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation
by: Takashi eTagami, et al.
Published: (2015-02-01) -
Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies
by: Daisuke Kudo, et al.
Published: (2021-03-01)